The difference was apparent in subjects from whom blood was collected several years before the diagnosis of the cancer, indicating that the low beta-carotene levels in the cancer subjects were unlikely to have been simply a consequence of pre-clinical disease.
← all excerpts
Serum beta-carotene and subsequent risk of cancer: results from the BUPA Study.
1
—
—